Cara Therapeutics | CARA - Umsatzerlöse

Aktienkurs
3.39
Täglich Wechseln
0.17 5.28%
Monatlich
-1.45%
Jährlich
-80.60%
Q2 Prognose
2.82




Der Umsatz Veränderung Datum
Acadia Pharmaceuticals USD 284M 5.4M 2025-12
Alterity Therapeutics Limited AUD 596.04K 584.66K 2025-12
Assertio Holdings USD 29.2M 1.92M 2024-09
Cara Therapeutics USD 2.57M 1.11M 2025-03
Chugai Pharma JPY 346.3B 13.12B 2025-12
Cipla INR 75.18B 710M 2025-12
Clal Biotechnology ILS 3.41M 2M 2022-12
Compugen USD 67.33M 65.44M 2025-12
CSL USD 8.33B 4.79B 2025-12
Grifols EUR 2.34B 33.3M 2026-03
Halozyme Therapeutics USD 451.76M 97.76M 2025-12
J&J USD 24.1B 500M 2026-03
Neurocrine Biosciences USD 805.5M 10.6M 2025-12
Pacira USD 196.87M 17.35M 2025-12
Pfizer USD 17.58B 880M 2025-12
RedHill Biopharma USD 1.29M 722K 2024-06
Supernus Pharmaceuticals USD 211.6M 19.5M 2025-12
Vanda Pharmaceuticals USD 198.77M 151.12M 2024-12